Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In VivoGangyang Wang, Chenhao Zhou|Frontiers in Pharmacology|2022Cited by 23